Latest News

Vaginal estrogen not recommended with aromatase inhibitors

Publish date: October 24, 2022

 

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

‘Flat denial’ can leave breast cancer patients with lasting scars
MDedge ObGyn
Tumor-bed radiotherapy boost reduces DCIS recurrence risk
MDedge ObGyn
Time to pull back on postsurgery radiation in breast cancer?
MDedge ObGyn
Stronger evidence that exercise lowers breast cancer risk
MDedge ObGyn
Sex is still a taboo subject for patients with breast cancer
MDedge ObGyn
FDA warns of cancer risk in scar tissue around breast implants
MDedge ObGyn
Genetic tests create treatment opportunities and confusion for breast cancer patients
MDedge ObGyn
Cost paramount when choosing metastatic breast cancer treatment
MDedge ObGyn
Reminder that COVID-19 and cancer can be a deadly combo
MDedge ObGyn
Hair straighteners’ risk too small for docs to advise against their use
MDedge ObGyn